Nuvalent Inc vs Vanguard S&P 500 ETF — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Vanguard S&P 500 ETF trades at $687.45. Which is the better fit depends on your goals.
| NUVL | VOO | |
|---|---|---|
Market Cap | $9.81B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $123.96 | $698.29 |
52-Week Low | $72.16 | $571.45 |
Enterprise Value | $8.52B | — |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.
Read more on VOO →